Terbinafine-induced dermatomyositis: A case report and literature review of drug-induced dermatomyositis

Journal of Cutaneous Pathology

Volumn 35, Issue 1, 2008, Pages 74-81

  Magro, Cynthia M ^a   Schaefer, Jochen T ^b   Waldman, James ^c   Knight, Deborah ^c   Seilstad, Kay ^d   Hearne, Deane ^c  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c OHIO STATE UNIVERSITY   (United States)

^d Richfield Laboratories   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TERBINAFINE;

ADULT; APOPTOSIS; ARTICLE; CASE REPORT; CELL DEATH; CELL ULTRASTRUCTURE; CYTOKINE PRODUCTION; DERMATOMYOSITIS; DRUG INDUCED DISEASE; ENDOTHELIAL DYSFUNCTION; HELPER CELL; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE TEST; MALE; MUCINOSIS; MUSCLE WEAKNESS; ONYCHOMYCOSIS; RASH; SKIN ATROPHY; SKIN BIOPSY; SKIN BLOOD VESSEL; WESTERN BLOTTING;

ANTIFUNGAL AGENTS; BLOTTING, WESTERN; COMPLEMENT MEMBRANE ATTACK COMPLEX; DERMATOMYOSITIS; ENDOTHELIUM, VASCULAR; FLUORESCENT ANTIBODY TECHNIQUE, DIRECT; GLUCOCORTICOIDS; HUMANS; MALE; MIDDLE AGED; MUSCLE WEAKNESS; NAPHTHALENES; PREDNISONE; WITHHOLDING TREATMENT;

EID: 37249076500     PISSN: 03036987     EISSN: 16000560     Source Type: Journal    
DOI: 10.1111/j.1600-0560.2007.00767.x     Document Type: Article

References (58)

1. Bohan A, Peter JB. Polymyositis and dermatomyositis (first of two parts). N Engl J Med 1975 292: 344.
2. Bohan A, Peter JB. Polymyositis and dermatomyositis (second of two parts). N Engl J Med 1975 292: 403.
3. Magro CM, Ross P, Marsh CB, et al. The role of anti-endothelial cell antibody-mediated microvascular injury in the evolution of pulmonary fibrosis in the setting of collagen vascular disease. Am J Clin Pathol 2007 127: 237.
4. Crowson AN, Magro CM. The role of microvascular injury in the pathogenesis of cutaneous lesions of dermatomyositis. Hum Pathol 1996 27: 15.
5. Kissel JT, Halterman RK, Rammohan KW, Mendell JR. The relationship of complement-mediated microvasculopathy to the histologic features and clinical duration of disease in dermatomyositis. Arch Neurol 1991 48: 26.
6. Kissel JT, Mendell JR, Rammohan KW. Microvascular deposition of complement membrane attack complex in dermatomyositis. N Engl J Med 1986 314: 329.
7. Bowyer SL, Ragsdale CG, Sullivan DB. Factor VIII related antigen and childhood rheumatic diseases. J Rheumatol 1989 16: 1093.
8. Crowson AN, Magro CM, Dawood MR. A causal role for parvovirus B19 infection in adult dermatomyositis and other autoimmune syndromes. J Cutan Pathol 2000 27: 505.
9. Magro CM, Crowson AN, Ferri C. Cytomegalovirus-associated cutaneous vasculopathy and scleroderma sans inclusion body change. Hum Pathol 2007 38: 42.
10. Dourmishev AL, Dourmishev LA. Dermatomyositis and drugs. Adv Exp Med Biol 1999 455: 187.
11. Fauchais AL, Iba Ba J, Maurage P, et al. Polymyositis induced or associated with lipid-lowering drugs: five cases. Rev Med Interne 2004 25: 294.
12. Dimachkie MM, Vriesendorp FJ, Heck KA. Phenytoin-induced dermatomyositis: case report and literature review. J Child Neurol 1988 13: 577.
13. Akiyama C, Osada A, Sou K, et al. A case of dermatomyositis triggered by tegafur. Acta Derm Venereol 1997 77: 490.
14. Dietrich LL, Bridges AJ, Albertini MR. Dermatomyositis after interferon alpha treatment. Med Oncol 2000 17: 64.
15. Varma S, Lanigan SW. Dermatomyositis-like eruption and leg ulceration caused by hydroxyurea in a patient with psoriasis. Clin Exp Dermatol 1999 24: 164.
16. Vela-Casasempere P, Borras-Blasco J, Navarro-Ruiz A. Alfuzosin-associated dermatomyositis. Br J Rheumatol 1998 37: 1135.
17. Flores-Suarez LF, Morales H, Angeles A, Kraus A. Drug-induced amyopathic dermatomyositis. J Clin Rheumatol 2002 8: 50.
18. Pan Y, Chong AH, Williams RA, Green J, Sinclair R. Omeprazole-induced dermatomyositis. Br J Dermatol 2006 154: 557.
19. Haga HJ, Haaland P, Haga T. Silicone breast implants and collagen disease. Tidsskr Nor Laegeforen 1992 112: 763.
20. Grob JJ, Collet AM, Bonerandi JJ. Dermatomyositis-like syndrome induced by nonsteroidal anti-inflammatory agents. Dermatologica 1989 178: 58.
21. Kass E, Straume S, Mellbye OJ, Munthe E, Solheim BG. Dermatomyositis associated with BCG vaccination. Scand J Rheumatol 1979 8: 187.
22. Crowson AN, Magro C. The cutaneous pathology of lupus erythematosus: a review. J Cutan Pathol 2001 28: 1.
23. Chen M, Crowson AN, Woofter M, Luca MB, Magro CM. Docetaxel (taxotere) induced subacute cutaneous lupus erythematosus: report of 4 cases. J Rheumatol 2004 31: 818.
24. Callen JP, Hughes AP, Kulp-Shorten C. Subacute cutaneous lupus erythematosus induced or exacerbated by terbinafine: a report of 5 cases. Arch Dermatol 2001 137: 1196.
25. Gubinelli E, Cocuroccia B, Girolomoni G. Subacute cutaneous lupus erythematosus induced by Nifedipine. J Cutan Med Surg 2003 7: 243.
26. Bonsmann G, Schiller M, Luger TA, Stander S. Terbinafine-induced subacute cutaneous lupus erythematosus. J Am Acad Dermatol 2001 44: 925.
27. Magro CM, Calomeni EP, Nadasdy T, Shusterman BD, Pope-Harman AL, Ross P Jr. Ultrastructure as a diagnostic adjunct in the evaluation of lung allograft biopsies. Ultrastruct Pathol 2005 29: 95.
28. Magro CM, Crowson AN. The immunofluorescent profile of dermatomyositis: a comparative study with lupus erythematosus. J Cutan Pathol 1997 24: 543.
29. Fujieda M, Oishi N, Naruse K, et al. Soluble thrombomodulin and antibodies to bovine glomerular endothelial cells in patients with Henoch-Schonlein purpura. Arch Dis Child 1998 78: 240.
30. Tsai CY, Yu CL, Wu TH, et al. Polyclonal anticardiolipin antibodies purified from sera of patients with active systemic lupus erythematosus induce apoptosis of the cultured glomerular mesangial cells. Scand J Rheumatol 2000 29: 370.
31. Sachsenberg-Studer EM, Prins C, Saurat JH, Salomon D. Raynaud's phenomenon, anticentromere antibodies, and digital necrosis without sclerodactyly: an entity independent of scleroderma? J Am Acad Dermatol 2000 43: 631.
32. Shingu M, Hurd ER. Sera from patients with systemic lupus erythematosus reactive with human endothelial cells. J Rheumatol 1981 8: 581.
33. Wusirika R, Ferri C, Marin M, et al. The assessment of anti-endothelial cell antibodies in scleroderma-associated pulmonary fibrosis. A study of indirect immunofluorescent and western blot analysis in 49 patients with scleroderma. Am J Clin Pathol 2003 120: 596.
34. Cines DB, Lyss AP, Reeber M, Bina M, DeHoratius RJ. Presence of complement-fixing anti-endothelial cell antibodies in systemic lupus erythematosus. J Clin Invest 1984 73: 611.
35. Jones SM, Mathew CM, Dixey J, Lovell CR, McHugh NJ. VCAM-1 expression on endothelium in lesions from cutaneous lupus erythematosus is increased compared with systemic and localized scleroderma. Br J Dermatol 1996 135: 678.
36. Majewski S, Hunzelmann N, Johnson JP, et al. Expression of intercellular adhesion molecule-1 (ICAM-1) in the skin of patients with systemic scleroderma. J Invest Dermatol 1991 97: 667.
37. Carter V, Shenton BK, Jaques B, et al. Vimentin antibodies: a non-HLA antibody as a potential risk factor in renal transplantation. Transplant Proc 2005 37: 654.
38. Rose ML. Role of antibodies in transplant-associated cardiac allograft vasculopathy. Z Kardiol 2000 89 Suppl. 9: IX/11.
39. Manoussakis MN, Constantopoulos SH, Gharavi AE, Moutsopoulos HM. Pulmonary involvement in systemic sclerosis. Association with anti-Scl 70 antibody and digital pitting. Chest 1987 92: 509.
40. Lee WS, Chen RJ, Wang YJ, et al. In vitro and in vivo studies of the anticancer action of terbinafine in human cancer cell lines: G0/G1 p53-associated cell-cycle arrest. Int J Cancer 2003 106: 125.
41. Wenzel J, Schmidt R, Proelss J, Zahn S, Bieber T, Tuting T. Type I interferon-associated skin recruitment of CXCR3+ lymphocytes in dermatomyositis. Clin Exp Dermatol 2006 31: 576.
42. Wenzel J, Scheler M, Bieber T, Tuting T. Evidence for a role of type I interferons in the pathogenesis of dermatomyositis. Br J Dermatol 2005 153: 462 author reply 463.
43. Caproni M, Torchia D, Cardinali C, et al. Infiltrating cells, related cytokines and chemokine receptors in lesional skin of patients with dermatomyositis. Br J Dermatol 2004 151: 784.
44. Greenberg SA, Pinkus JL, Pinkus GS, et al. Interferon-alpha/beta-mediated innate immune mechanisms in dermatomyositis. Ann Neurol 2005 57: 664.
45. Kanda N, Enomoto U, Watanabe S. Anti-mycotics suppress interleukin-4 and interleukin-5 production in anti-CD3 plus anti-CD28-stimulated T cells from patients with atopic dermatitis. J Invest Dermatol 2001 117: 1635.
46. Gimenes VM, Criado PR, Martins JE, Almeida SR. Cellular immune response of patients with chromoblastomycosis undergoing antifungal therapy. Mycopathologia 2006 162: 97.
47. Tang D, Park HJ, Georgescu SP, Sebti SM, Hamilton AD, Galper JB. Simvastatin potentiates tumor necrosis factor alpha-mediated apoptosis of human vascular endothelial cells via the inhibition of the geranylgeranylation of RhoA. Life Sci 2006 5: 1484.
48. Wojnarowska F. Dermatomyositis induced by penicillamine. J R Soc Med 1980 73: 884.
49. Schalke BB, Schmidt B, Toyka K, Hartung HP. Pravastatin associated inflammatory myopathy. N Engl J Med 1992 327: 649.
50. Khattak FH, Morris IM, Branford WA. Simvastatin-associated dermatomyositis. Br J Rheumatol 1994 33: 199.
51. Rodriguez-Garcia JL, Serrano Commino M. Lovastatin-associated dermatomyositis. Postgrad Med J 1996 72: 694.
52. Hill C, Zeitz C, Kirkham B. Dermatomyositis with lung involvement in a patient treated with simvastatin. Aust N Z J Med 1995 25: 745.
53. Zuech P, Pauwels C, Duthoit C, et al. Pravastatin-induced dermatomyositis. Rev Med Interne 2005 26: 897.
54. Thual N, Penven K, Chevallier JM, Dompmartin A, Leroy D. Fluvastatin-induced dermatomyositis. Ann Dermatol Venereol 2005 132: 996.
55. Gomez Rodriguez N, Zulaica Garate A. Development of dermatomyositis in a woman with rheumatoid arthritis treated with leflunomide. An Med Interna 2005 22: 300.
56. Akiyama C, Osada A, Sou K, et al. A case of dermatomyositis triggered by tegafur. Acat Derm Venereol 1997 77: 490.
57. Curran JJ, Jamieson TW. Dermatomyositis-like syndrome associated with phenylbutazone therapy. J Rheumatol 1987 14: 397.
58. Fusella J, Strosberg JM. Polymyositis exacerbated by gemfibrozil. J Rheumatol 1990 17: 572.